iMPROVE

• Research type

  Research Study

• Full title

  Innovation in person-centred Medication Prescribing and Review for Optimal Value and Efficacy (iMPROVE)

• IRAS ID

  359637

• Contact name

  David Gibson

• Sponsor organisation

  Ulster University

• Duration of Study in the UK

  3 years, 0 months, 1 days

• Research summary

  The iMPROVE study aims to improve the safety and effectiveness of commonly prescribed medications through person-centred medication reviews. The project hopes to help people in rural and urban communities in counties Tyrone, Derry/Londonderry, Donegal, Sligo and Tayside in Scotland).
  
  There are two ways that iMPROVE will do this:
  
  1. Offer a person-centred medication review with a trained GP or pharmacist who will work together with the patient to review their current medications and discuss ways to improve medication safety and outcomes.
  
  2. Offer a pharmacogenomic test (a test using a blood or saliva sample that looks at the patient’s genes to help predict how their body will respond to certain medicines) for common medications to help guide prescribing decisions and avoid potential side effects.
  
  Anyone who agrees to participate in this study will be offered a person-centred medication review. This review will involve an appointment with a GP or pharmacist who will discuss what matters to the patient about their medicines and health and what they would like to achieve, the medications they currently take, or are about to start, and any difficulties they may have with these medications. This may include things such as a reduction in side effects or better relief of symptoms.
  

• REC name

  Wales REC 6

• REC reference

  26/WA/0078

• Date of REC Opinion

  23 Apr 2026

• REC opinion

  Further Information Favourable Opinion